TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
BioPhausia AB
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
14,414
|
17,072
|
20,646 |
Financial expenses |
20
|
55
|
20 |
Earnings before taxes |
8,832
|
10,708
|
12,945 |
EBITDA |
8,875
|
10,761
|
12,832 |
Total assets |
27,164
|
28,187
|
33,141 |
Current assets |
26,627
|
27,635
|
32,816 |
Current liabilities |
12,524
|
12,158
|
17,655 |
Equity capital |
14,640
|
15,799
|
15,265 |
- share capital |
49
|
50
|
48 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
53.9%
|
56.1%
|
46.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
61.3%
|
62.7%
![]() |
62.7% |
Return on assets (ROA) |
32.6%
|
38.2%
|
39.1% |
Current ratio |
212.6%
|
227.3%
|
185.9% |
Return on equity (ROE) |
60.3%
|
67.8%
|
84.8% |
Change turnover |
-2,342
|
-4,389
|
226 |
Change turnover % |
-14%
|
-20%
|
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.